Phase 1 study of veliparib with carboplatin and weekly paclitaxel in Japanese patients with newly diagnosed ovarian cancer

This phase 1, open‐label, dose‐escalation study was conducted to determine the safety, tolerability, pharmacokinetics and preliminary efficacy of veliparib with carboplatin and weekly paclitaxel in Japanese women with newly diagnosed, advanced ovarian cancer. Patients received veliparib at 100 or 15...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishio, Shin, Takekuma, Munetaka, Takeuchi, Satoshi, Kawano, Kouichirou, Tsuda, Naotake, Tasaki, Kazuto, Takahashi, Nobutaka, Abe, Masakazu, Tanaka, Aki, Nagasawa, Takayuki, Shoji, Tadahiro, Xiong, Hao, Nuthalapati, Silpa, Leahy, Terri, Hashiba, Hideyuki, Kiriyama, Tsukasa, Komarnitsky, Philip, Hirashima, Yasuyuki, Ushijima, Kimio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665762/
https://www.ncbi.nlm.nih.gov/pubmed/28837250
http://dx.doi.org/10.1111/cas.13381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665762/
https://www.ncbi.nlm.nih.gov/pubmed/28837250
http://dx.doi.org/10.1111/cas.13381

Ejemplares similares